Health Protection (Coronavirus, Restrictions) (No. 2) (England) (Amendment) (No. 5) Regulations 2020

Lord Moylan Excerpts

Tuesday 20th October 2020 Lords Chamber

[Lord Moylan (Con)]

My Lords, it is a great privilege to speak after the noble Baroness, Lady Fox of Buckley, who brings to the House her experience of the European Parliament, where she represented the north-west of England. Like many of her constituents there, she is and has been a doughty defender of Brexit and taking back control of our laws. She also has the unique distinction of being the longest-serving panellist on the BBC’s programme “Moral Maze”, dispensing ethical guidance to the nation. I am sure that if noble Lords felt they would like some ethical guidance, she would be willing to offer an open ear. She is a defender of free speech, as we have heard—a cause that must commend itself to your Lordships’ House, which manages to combine freedom from legal limitation on what it says with courteous and quintessentially rational debate.

On the subject of the Motion, the acid test is not infections but deaths. While these have been rising, they have been rising much more slowly than infections. For example, in the Evening Standard yesterday we learned that deaths in London over the past seven days have been running at a rate 1/50th of the height of the pandemic. This is good news, and we owe a great deal of that to the skill, experience and intuition of medical professionals, who have learned as time has gone on how better to treat and to care for those suffering from this dreadful disease. We owe them a great debt, as so often in this pandemic.

Mortality rates in ICU have come down from 40% to 15%. This points the way to the future, because while we would all like a silver bullet that will put an end to this pandemic, in practice we are much more likely to have to live with it for many years and rely on advances in care and treatment to make it ever less fatal. My question to the Minister is simply: can he assure the House that the Government’s attention is on improving treatment and care as much as on apps and vaccines?